Overview

As the industry continues to rethink the profile of medical affairs, it must seek out new competencies, technology solutions, and data sources that better support patient-centric outcomes. Medical affairs leaders are at the forefront of this evolution and newly positioned to rewrite the traditional corporate formula for success. Understanding and analysing the scientific share of voice of competitive compounds has become increasingly critical when evolving commercialisation strategies. These highly specific insights create a foundation for continuous improvements and opportunities to act with greater focus. These efforts allow teams to accurately benchmark external relations and inform strategic engagement.
As innovation increases the complexity of care and the scientific demand of the treating community grows, the ability to identify and engage community leaders using insights from medical claims data is now critical for long-term success.